Skip to content

2029 at other companies

Revvity logo
RevvityRVTY
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$1.1B+7.9%
Gross profit$735.4M+8.3%
Operating income-$31.0M-117%
Net income-$77.9M-189%
EPS (diluted)-$0.40-191%

Balance sheet

See full
Cash & equivalents$139.0M+19.6%
Total debt$3.1B+15.6%
Total equity$8.2B-0.6%
Total assets$12.5B+0.6%

Cash flow

See full
Operating cash flow$182.8M+90.0%
CapEx$86.4M+10.6%
Free cash flow$96.4M+433%

Valuation

See full
Market cap$12.85B-25.7%
Enterprise value$15.78B-20.2%
P/E54.5×+12.8×
P/S-1.3×

Profitability

See full
Gross margin65.5%-1.6pp
Operating margin11.8%-7.2pp
Net margin5.6%-4.8pp
FCF margin13.5%+4.3pp

Returns & leverage

See full
Return on equity2.9%-2.3pp
Debt / equity0.4×+0.1×
Current ratio1.3×-0.8×

Where this comes from

Reported directly by The Cooper Companies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree.

The official record: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Cooper Companies, Inc.'s 2029.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Cooper Companies, Inc.'s 2029?
The Cooper Companies, Inc. (COO) reported 2029 of $166M in Q1 2026.
How has The Cooper Companies, Inc.'s 2029 changed year-over-year?
The Cooper Companies, Inc.'s 2029 decreased by 3.3% year-over-year, from $171.6M to $166M.